ALLIANCE PHARMA INC. – Trademark Portfolio
Entity Type: 03
ALLIANCE PHARMA INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 7 trademarks are registered and 11 are pending. Notable registered marks include AMBEREN, SMART-B, RESOLIAN, RESOLIAN BIOANALYTICS, and FEEL LIKE YOURSELF AGAIN. The owner is based in CARY, NC.
11000 REGENCY PKWY
STE 106
CARY, NC 27518
Showing of trademarks Trademarks
Trademark Classifications
ALLIANCE PHARMA INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ALLIANCE PHARMA INC. have?
ALLIANCE PHARMA INC. has 19 U.S. trademarks filed with the USPTO. Of these, 7 registered, 11 pending, 1 cancelled.
What trademark classes does ALLIANCE PHARMA INC. file in?
ALLIANCE PHARMA INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ALLIANCE PHARMA INC.'s most well-known trademarks?
ALLIANCE PHARMA INC.'s registered trademark portfolio includes well-known marks such as AMBEREN, SMART-B, RESOLIAN, RESOLIAN BIOANALYTICS, and FEEL LIKE YOURSELF AGAIN. These are among 7 currently registered trademarks in the portfolio.
What is ALLIANCE PHARMA INC.'s trademark registration success rate?
ALLIANCE PHARMA INC. has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 11 applications are pending review.